ModelEdge

Arca Biopharma Inc.
ABIO
Filing TypeS-3
Filing Date10/2/2025
Updated10/3/25, 3:28 PM

Filing

S-3
Earnings Release

Exhibits

S-3Registration Statement for Securities Offered under a Shelf Registration
EX-1.2SALES AGREEMENT BETWEEN ORUKA THERAPEUTICS, INC. AND TD SECURITIES (USA) LLC, DATED OCTOBER 3, 2025
EX-5.1OPINION OF DAVIS POLK & WARDWELL LLP RELATING TO THE BASE PROSPECTUS
EX-5.2OPINION OF DAVIS POLK & WARDWELL LLP RELATING TO THE SALES AGREEMENT PROSPECTUS
EX-23.1CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-FILING FEESFILING FEE TABLE
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic